Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 901629 | ISIN: US3030751057 | Ticker-Symbol: FA1
Tradegate
21.01.25
17:14 Uhr
448,70 Euro
-3,50
-0,77 %
1-Jahres-Chart
FACTSET RESEARCH SYSTEMS INC Chart 1 Jahr
5-Tage-Chart
FACTSET RESEARCH SYSTEMS INC 5-Tage-Chart
RealtimeGeldBriefZeit
445,00449,0021.01.
446,20448,9021.01.
PR Newswire
246 Leser
Artikel bewerten:
(1)

Investor Technology Group, Inc.: Mosaic Announces Strategic Integration with FactSet Data to Streamline Public-to-Private Deal Modeling

Finanznachrichten News

NEW YORK, Dec. 16, 2024 /PRNewswire/ -- Mosaic, the world's leading Digital Deal Modeling platform, today announced the release of its integration with FactSet, supercharging the Mosaic platform with high quality financial data from FactSet for mutual customers. FactSet's financial and market data will automatically populate Mosaic's deal modeling engine for seamless, rapid screening of public-to-private transactions.

Mosaic's automated model builder powered by FactSet data.

This integration empowers private equity firms and investment banks using Mosaic to conduct complex take-private analysis in under one minute, leveraging FactSet's extensive datasets, including fundamental financials, consensus estimates, and real-time market pricing - paired with the user's differentiated judgments on appropriate capital structure and exit for the deal.

"We're excited to integrate FactSet's trusted data into Mosaic's advanced platform to enhance the research capabilities available to FactSet and Mosaic users," said Jason Weinstein, Head of the Private Equity and Venture Capital Business Unit at FactSet. "FactSet's integration will deliver robust datasets that enable users to better understand market trends and conduct more thorough and efficient deal screening and analysis."

With this integration, dealmakers can now accelerate their deal idea generation processes by completing analyses in minutes - what used to take hours in legacy, spreadsheet-based workflows. Mosaic's innovative platform, renowned for its precision and efficiency in deal modeling, is now further enhanced by FactSet's high-quality data, enabling faster, more accurate insights for better-informed investment decisions.

"Mosaic's collaboration with FactSet represents a major leap forward in analytical capacity and capability for our shared customers," said Ian Gutwinski, Founder & CEO of Mosaic. "By combining the advanced modeling capabilities of Mosaic with FactSet's trusted data, we're able to offer an unparalleled solution for transaction screening and analysis, reducing time spent on manual data collection and allowing users to focus on high-impact assumptions around a deal's base case forecast, capitalization and exit."

This integration aligns with Mosaic's mission to provide financial professionals with cutting-edge tools that simplify complex financial transactions, offering greater speed and accuracy in a competitive market. With FactSet's data now available within Mosaic's platform, users can now screen new opportunities with a level of agility previously unattainable.

For more information on the Mosaic platform and the new FactSet integration, visit https://mosaic.pe/integrations. To enable the integration, contact your dedicated Mosaic or FactSet representative or email info@mosaic.pe.

About Investor Technology Group, Inc. (doing business as Mosaic):
Investor Technology Group is digitizing the private equity front office through its pioneering Digital Deal Modeling platform, Mosaic.

Thousands of the world's best investment professionals at firms managing over half a trillion of assets including Warburg Pincus, CVC, New Mountain Capital, Bridgepoint, Ontario Teachers' Pension Plan, The Riverside Company, and many more leverage the Mosaic platform to efficiently screen a world of opportunity and identify the handful of investments worthy of their portfolios.

By combining our founding team's deep sector expertise with cutting edge digital technologies - and the collective intelligence of our pioneering user base - we're building the future of private equity. To be a part of that future, visit www.mosaic.pe and follow us on LinkedIn.

About FactSet

FactSet (NYSE:FDS | NASDAQ:FDS) helps the financial community to see more, think bigger, and work better. Our digital platform and enterprise solutions deliver financial data, analytics, and open technology to more than 8,200 global clients, including over 216,000 individual users. Clients across the buy-side and sell-side as well as wealth managers, private equity firms, and corporations achieve more every day with our comprehensive and connected content, flexible next-generation workflow solutions, and client-centric specialized support. As a member of the S&P 500, we are committed to sustainable growth and have been recognized amongst the Best Places to Work in 2023 by Glassdoor as a Glassdoor Employees' Choice Award winner. Learn more at?www.factset.com ?and follow us on?X?and?LinkedIn.

Press Contact:
Manasa Grandhi
Director of Operations
manasa@mosaic.pe
https://mosaic.pe

Mosaic Logo

Photo - https://mma.prnewswire.com/media/2581737/Mosaic_FactSet.jpg
Logo - https://mma.prnewswire.com/media/2254133/Investor_Technology_Group_Mosaic.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/mosaic-announces-strategic-integration-with-factset-data-to-streamline-public-to-private-deal-modeling-302332298.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.